about
Sexual Transmission of Zika Virus and Persistence in Semen, New Zealand, 2016Acute Zika infection with concurrent onset of Guillain-Barré SyndromeStrengthening the influenza vaccine virus selection and development process: Report of the 3rd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014.Seasonal influenza vaccine policies, recommendations and use in the World Health Organization's Western Pacific Region.Influenza in the Asia-Pacific region: Findings and recommendations from the Global Influenza Initiative.Tracking oseltamivir-resistance in New Zealand influenza viruses during a medicine reclassification in 2007, a resistant-virus importation in 2008 and the 2009 pandemic.Cold, dry air is associated with influenza and pneumonia mortality in Auckland, New ZealandInfluenza surveillance and immunisation in New Zealand, 1997-2006.Pandemic influenza A(H1N1)v viruses currently circulating in New Zealand are sensitive to oseltamivir.Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009.Genotyping assay for the identification of 2009-2010 pandemic and seasonal H1N1 influenza virus reassortants.Pandemic Seasonal H1N1 Reassortants Recovered from Patient Material Display a Phenotype Similar to That of the Seasonal Parent.Transmissibility of 2009 pandemic influenza A(H1N1) in New Zealand: effective reproduction number and influence of age, ethnicity and importations.The impact of the pandemic influenza A(H1N1) 2009 virus on seasonal influenza A viruses in the southern hemisphere, 2009.Pandemic (H1N1) 2009 and seasonal influenza A (H1N1) co-infection, New Zealand, 2009Therapy of experimental human brain tumors using a neuroattenuated herpes simplex virus mutant.Acute flaccid paralysis from echovirus type 33 infection.Enterovirus 74 infection in children.The contrasting phylodynamics of human influenza B viruses.Identification of Enterovirus C105 for the first time in New Zealand.Effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2013Detection and whole genome sequence analysis of an enterovirus 68 cluster.Environmental poliovirus surveillance during oral poliovirus vaccine and inactivated poliovirus vaccine use in Córdoba Province, ArgentinaDiagnostic assay recommended by the world health organization for swine origin influenza a (h1n1) virus cross-reacts with H5N1 influenza virus.Evaluation of rapid and simple techniques for the enrichment of viruses prior to metagenomic virus discovery.Effectiveness of seasonal influenza vaccine in preventing influenza primary care visits and hospitalisation in Auckland, New Zealand in 2015: interim estimates.Modelled seasonal influenza mortality shows marked differences in risk by age, sex, ethnicity and socioeconomic position in New Zealand.Influenza vaccine effectiveness for hospital and community patients using control groups with and without non-influenza respiratory viruses detected, Auckland, New Zealand 2014.Estimating the contribution of influenza to hospitalisations in New Zealand from 1994 to 2008.An in vitro ligation and transfection system for inserting DNA sequences into the latency-associated transcripts (LATs) gene of herpes simplex virus type 1.Interim estimates of the effectiveness of seasonal trivalent inactivated influenza vaccine in preventing influenza hospitalisations and primary care visits in Auckland, New Zealand, in 2014.Correction: Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination?Literature review of the epidemiology of influenza B disease in 15 countries in the Asia-Pacific region.Strengthening the influenza vaccine virus selection and development process: outcome of the 2nd WHO Informal Consultation for Improving Influenza Vaccine Virus Selection held at the Centre International de Conférences (CICG) Geneva, Switzerland, 7 tDistinct patterns of evolution between respiratory syncytial virus subgroups A and B from New Zealand isolates collected over thirty-seven years.Persistence of oral polio vaccine virus after its removal from the immunisation schedule in New Zealand.beta-Gal enzyme activity driven by the HSV LAT promoter does not correspond to beta-gal RNA levels in mouse trigeminal ganglia.A cross-sectional survey of influenza A infection and management practices in small rural backyard poultry flocks in New Zealand.Rotavirus hospitalisation in New Zealand children under 3 years of age.A case of conjunctivitis associated with oral poliovirus type 2 vaccine (OPV).
P50
Q26247000-DAD1C779-F9FF-4F25-8642-B68A6D4428E8Q26252126-722BAA62-AEE4-4A40-BDBA-903FC3974A54Q30203189-C08873CA-7049-43F8-BB4B-BFC28A2C07F4Q30218410-D0D4A2E5-4CB3-41CC-83D5-CB2C8E10097AQ30239048-85C423AA-F330-446E-BCA3-F37EB952F355Q30352557-97EFB97E-2BC4-4DE2-9207-5D8AF09CC582Q30357918-3D175D3D-1565-4A3A-9C7A-EE8ED7BC826CQ30377231-C9289725-C75A-4554-BEB8-0C88396A1674Q30379402-A4A80682-FC77-482D-AFA3-754CDF9A9996Q30380176-E7E7164C-4010-4C43-81A5-4C61C594AB9CQ30388744-76C6D707-7E2D-4317-8265-ECFF08F881E9Q30389102-2C86797B-9D61-4C27-9000-4EA48738CC65Q30390706-A0EDD6C8-D88C-4386-BA95-BC2534286AB0Q30392941-2674071F-B15F-4C24-9C73-70225D09B19DQ30394182-B35E6D39-5B25-4481-A81C-8B8E54D73A8AQ34288445-35B61FB4-76B5-4917-98F4-56EC2EAFEE45Q34990671-98565132-91B8-4C05-8767-BCF636BFB723Q35009481-184CDEDE-730B-4C72-9AF4-7715CF76AC2EQ35249640-7C9AE001-44E0-498B-A860-E0FC3D2C3F89Q35539319-1FB3BD0A-B538-4835-885D-A351ACED1054Q36232932-8FA2CBEE-A4DF-48BF-84E8-71E1A5D5D976Q36753070-336FFC70-D6D6-4E2C-B510-D88CE0CEEDF4Q37110431-6C58190A-3248-4D56-B238-859C36A72855Q37410487-77A442D3-38E1-44C3-ABC7-11314992FDC1Q38137615-4BDC4D8B-D839-4E07-A850-AD5E0951FED2Q40107978-EE9F75B5-3AA9-4D81-8308-F1E598323E09Q40173454-6ACADAEB-6A3B-4C23-95AC-FA349010BC6AQ40191494-BEEF9472-17FE-4060-8442-4E9E41494F84Q40768033-BC8E4907-5D7F-4AD5-B886-D5DC76E9C5EFQ41446584-D8FE33C6-86DC-4C0B-BA8F-5456C3868E4BQ42182563-E58ABE84-B9F2-4F41-9CEA-A89D46BEA9EEQ42843505-D4B28AFA-C759-43AA-9511-EE1A518F16DEQ43167533-9AC5BA16-A5BF-433D-AC73-BFEBB6AACBEAQ43436136-2B40D4A7-FB82-4D11-9AD7-83A656D759ECQ45413095-1EB512BB-1D26-4FF9-BFC0-EF39436B61C5Q45428946-DFFA9688-A73F-437C-83D2-ECE8AB786E02Q45883846-439191A4-DEA5-4D14-A03E-9194E75B5E4AQ47616265-7A72B676-6C41-41B9-9BB0-D3805D38AE77Q53256813-51EFE333-4217-4379-8148-84D1A00E161AQ54701461-91BF94B2-87F7-4FD2-B096-D9AA69C528A3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sue Huang
@ast
Sue Huang
@en
Sue Huang
@es
Sue Huang
@nl
type
label
Sue Huang
@ast
Sue Huang
@en
Sue Huang
@es
Sue Huang
@nl
altLabel
Q S Huang
@en
Q. Sue Huang
@en
Qui Sue Huang
@en
prefLabel
Sue Huang
@ast
Sue Huang
@en
Sue Huang
@es
Sue Huang
@nl
P1153
P106
P1153
55257388900
57202884840
57207393785
57212622872
P166
P1960
Q1EKwKgAAAAJ
YShuwAcAAAAJ
P2038
Sue_Huang4
P21
P31
P496
0000-0002-3923-5195